Assyro AI

FDA Orange Book · active-ingredient family

Estradiol acetate

Estradiol acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:FEMTRACE · NDA 021633

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · insert, extended release, tablet

ProductApplicantApplicationTEApproved
FEMTRACERLD×3APILNDA 021633Aug 20, 2004
FEMRINGRLD×2MILLICENT MFG PRNDA 021367Mar 20, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Estradiol acetate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.